Page 50 - Arix Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board Mon, 26th Apr 2021 16:02 (Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Ebiquity PLC - marketing and media consultancy - Appoints Lara Izlan as non-executive director with effect on June 1. Is currently director of Data Strategy at FTSE-250 listed broadcaster ITV PLC. Arix Bioscience PLC - firm which invests in biotech companies - Acacia Research Corp, a 19% shareholder in Arix will requisition resolutions for ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Arix Bioscience PLC: Transaction in own shares DJ Transaction in own shares Arix Bioscience PLC (ARIX) Transaction in own shares 19-Apr-2021 / 17:09 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Arix Bioscience plc Transaction in own shares LONDON, 19 April 2021: Arix Bioscience plc ("Arix" or "the Company"), a global venture capital company focused on investing in...

DJ Transaction in own shares Arix Bioscience PLC (ARIX) Transaction in own shares 12-Apr-2021 / 17:22 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is

Shareholder broadside at biotech investor Arix’s board 10 April 2021 • 8:20pm Acacia Research last year bought the 19pc stake in Arix Bioscience that was previously owned by Neil Woodford's fund Credit: Geoff Pugh Arix Bioscience, the biotechnology investor backed by restaurant tycoon Richard Caring and biotech entrepreneur Sir Christopher Evans, has been forced to halt two board appointments after its largest shareholder called for a total overhaul in a scathing letter. Mayfair-based Arix has had to pause the planned hire of two directors due to join the business this month after Acacia ...